A detailed history of Israel Englander (Millennium Management LLC) transactions in Fibrogen Inc stock. As of the latest transaction made, Millennium Management LLC holds 2,103,614 shares of FGEN stock, worth $652,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,103,614
Previous 116,250 1709.56%
Holding current value
$652,120
Previous $273,000 585.71%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.89 - $2.36 $1.77 Million - $4.69 Million
1,987,364 Added 1709.56%
2,103,614 $1.87 Million
Q1 2024

May 15, 2024

SELL
$0.73 - $2.73 $358,546 - $1.34 Million
-491,159 Reduced 80.86%
116,250 $273,000
Q4 2023

Feb 14, 2024

SELL
$0.38 - $0.91 $1.06 Million - $2.55 Million
-2,800,988 Reduced 82.18%
607,409 $540,000
Q2 2023

Aug 14, 2023

BUY
$2.49 - $20.59 $7 Million - $57.9 Million
2,810,468 Added 470.03%
3,408,397 $9.2 Million
Q1 2023

May 15, 2023

BUY
$15.95 - $25.18 $6.73 Million - $10.6 Million
421,729 Added 239.35%
597,929 $11.2 Million
Q4 2022

Feb 14, 2023

BUY
$13.27 - $17.73 $1.93 Million - $2.58 Million
145,630 Added 476.38%
176,200 $2.82 Million
Q3 2022

Nov 14, 2022

SELL
$11.4 - $14.6 $663,776 - $850,099
-58,226 Reduced 65.57%
30,570 $398,000
Q2 2022

Aug 15, 2022

BUY
$7.94 - $12.96 $602,669 - $983,702
75,903 Added 588.71%
88,796 $938,000
Q1 2022

May 16, 2022

SELL
$12.02 - $16.79 $1.38 Million - $1.93 Million
-114,837 Reduced 89.91%
12,893 $155,000
Q4 2021

Feb 14, 2022

SELL
$9.93 - $15.39 $5.85 Million - $9.07 Million
-589,577 Reduced 82.19%
127,730 $1.8 Million
Q3 2021

Nov 15, 2021

BUY
$10.18 - $26.64 $7.19 Million - $18.8 Million
705,827 Added 6148.32%
717,307 $7.33 Million
Q2 2021

Aug 16, 2021

BUY
$18.57 - $35.68 $70,807 - $136,047
3,813 Added 49.73%
11,480 $306,000
Q1 2021

May 17, 2021

SELL
$31.0 - $55.72 $1.47 Million - $2.63 Million
-47,262 Reduced 86.04%
7,667 $266,000
Q4 2020

Feb 16, 2021

BUY
$37.09 - $48.97 $1.71 Million - $2.25 Million
46,006 Added 515.59%
54,929 $2.04 Million
Q3 2020

Nov 16, 2020

SELL
$40.47 - $45.5 $6.55 Million - $7.37 Million
-161,894 Reduced 94.78%
8,923 $367,000
Q2 2020

Aug 14, 2020

BUY
$32.57 - $42.83 $2.43 Million - $3.2 Million
74,713 Added 77.74%
170,817 $6.92 Million
Q1 2020

May 14, 2020

BUY
$23.3 - $45.96 $2.11 Million - $4.16 Million
90,617 Added 1651.49%
96,104 $3.34 Million
Q4 2019

Feb 14, 2020

SELL
$34.58 - $48.06 $1.81 Million - $2.51 Million
-52,275 Reduced 90.5%
5,487 $235,000
Q3 2019

Nov 14, 2019

BUY
$36.98 - $48.45 $2.14 Million - $2.8 Million
57,762 New
57,762 $2.14 Million
Q2 2019

Aug 14, 2019

SELL
$35.13 - $55.53 $5.88 Million - $9.29 Million
-167,368 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$42.83 - $59.91 $6.92 Million - $9.69 Million
161,667 Added 2835.77%
167,368 $9.1 Million
Q4 2018

Feb 14, 2019

SELL
$37.97 - $60.16 $3.83 Million - $6.07 Million
-100,893 Reduced 94.65%
5,701 $264,000
Q3 2018

Nov 14, 2018

BUY
$56.3 - $67.25 $5.3 Million - $6.33 Million
94,056 Added 750.17%
106,594 $6.48 Million
Q2 2018

Aug 14, 2018

SELL
$44.9 - $64.95 $3.96 Million - $5.73 Million
-88,221 Reduced 87.56%
12,538 $785,000
Q1 2018

May 15, 2018

BUY
$45.35 - $61.65 $3.78 Million - $5.14 Million
83,404 Added 480.58%
100,759 $4.66 Million
Q4 2017

Feb 14, 2018

BUY
$41.95 - $60.1 $728,042 - $1.04 Million
17,355
17,355 $823,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $29.1M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.